A Phase 2, Randomized, Double-blind, Placebo-controlled, 24-Week Study to Evaluate the Efficacy, Safety, and Tolerability of BBT-877, as mono- or add on therapy, in Patients with Idiopathic Pulmonary Fibrosis (IPF)

Project Details

StatusActive
Effective start/end date12/09/2226/09/25

Funding

  • PPD PTY LTD: A$117,192.00